T
45
-3
AIG
39
-5
DG
10
-2
WMB
70
-2
XOM
48
-2
NSC
62
-3
MMC
65
3
PBI
66
-4
HPQ
62
3
FCX
54
-5
C
64
-3
IFF
51
-3
GLW
53
-2
SLG
66
-7
LMT
40
-2
JNJ
38
-3
NI
70
-5
FRT
46
-4
WHR
66
-7
AIZ
75
2
T
45
-3
AIG
39
-5
DG
10
-2
WMB
70
-2
XOM
48
-2
NSC
62
-3
MMC
65
3
PBI
66
-4
HPQ
62
3
FCX
54
-5
C
64
-3
IFF
51
-3
GLW
53
-2
SLG
66
-7
LMT
40
-2
JNJ
38
-3
NI
70
-5
FRT
46
-4
WHR
66
-7
AIZ
75
2
Financhill
Back

Rocket Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
33

RCKT
Rocket Pharmaceuticals

Last Price:
15.68
Seasonality Move:
12.47%
Sell
47

APLS
Apellis Pharmaceuticals

Last Price:
28.30
Seasonality Move:
20.78%
Sell
33
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $16.03. The Score for RCKT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $16.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $29.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 38.55 Sell
Chaikin Money Flow: -799252 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.64 - 17.74) Sell
Bollinger Bands (100): (17.13 - 22.05) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 52.74 Buy
Chaikin Money Flow: 179519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.95 - 28.71) Buy
Bollinger Bands (100): (29.49 - 39.35) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.02 Sell
20-day SMA: 17.27 Sell
50-day SMA: 17.95 Sell
200-day SMA: 22.47 Sell
8-day EMA: 16.92 Sell
20-day EMA: 17.18 Sell
50-day EMA: 17.96 Sell
200-day EMA: 20.73 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.88 Buy
20-day SMA: 28.02 Buy
50-day SMA: 30.86 Sell
200-day SMA: 43.85 Sell
8-day EMA: 28.92 Buy
20-day EMA: 28.61 Buy
50-day EMA: 30.58 Sell
200-day EMA: 40.41 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.27 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):